Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumours.
Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumours.
复制标题
全氟化合物乳液 FMIQ 对 EMT6 肿瘤放射反应的影响。
DOI:
10.1080/09553009214551711
复制
发表时间:
1992
影响因子:
2.6
通讯作者:
Irvin,CG
中科院分区:
文献类型:
--
作者:
Rockwell,S;Kelley,M;Irvin,CG
The effects of FMIQ, a perfluorochemical emulsion based on perfluoro-N-methyldecahydroisoquinoline, were examined using BALB/c mice and EMT6 mammary carcinomas. The radiobiological effects of FMIQ were similar to those found previously for Fluosol® in the same tumour/host system. Although the perfluorochemical content (20% w/v) and oxygen-carrying capacity of FMIQ are similar to those of Fluosol, the formulation of FMIQ offers some advantages over that of Fluosol. For example, FMIQ has greater stability during storage. FMIQ also is fomulated without pluronic F-68 and is based on a perfluorochemical (FMIQ) having a shorter tissue dwell time than the perfluorotripropylamine in Fluosol; it therefore may produce fewer side-effects than Fluosol. The lifetime of the circulating perfluorochemical droplets in BALB/c mice was longer than FMIQ than for Fluosol; this could offer an advantage in fractionated radiotherapy. These findings give reason to expect that FMIQ may prove to be a better emulsion than Fluosol for clinical use as an adjunct to cancer therapy.